Pan et al. reported the extracellular matrix-associated protein SPARC was highly expressed in DLBCL and might be a favorable prognostic biomarker for DLBCL (Pan and Liu, 2021). The gene discussed is SPARC; the disease is diffuse large B-cell lymphoma.